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The protozoan parasites of the genus Trypanosoma sp.
and Leishmania sp. are responsible for neglected dis-
eases like Chagas’ disease, African sleeping sickness or
Leishmaniasis. The trypanothione synthetase (TryS) is
an attractive new drug target for the development of
trypanocidal and antileishmanial drugs [1].
In our virtual screening campaign for targeting the
trypanothione synthetase (TryS) we used representative
protein conformations derived from a computational
analysis using molecular dynamics (MD) simulations of
this key component of trypanothione biosynthesis. The
publicly available crystal structure lacks a variable loop
region that is known to be important for trypanothione
biosynthesis. MD simulations turned out to be a good
tool to model this loop region and obtain a more com-
plete set of protein conformations for subsequent use in
virtual screening [2].
For creating a structure-based consensus pharmaco-
phore model, Superstar [3] was deployed to generate
favourable non-bonded interaction maps of different
functional groups (probes) for all representative protein
conformations. The pharmacophore model was then
created for the rigid part of the binding pocket based on
high- propensity peaks of these maps. The variable loop
region was left out since it can not be depicted by this
approach. To include also multiple conformations of the
variable loop region, the new ensemble docking feature
of Gold was used [4]. After a pharmacophore search
within the ZINC database the retrieved molecules were
simultaneously docked to the different protein confor-
mations to identify the best combination of ligand pose
and protein conformer. Finally, several high-scoring
molecules were selected for further testing.
We will discuss in detail this combined pharmaco-
phore/ensemble docking approach based on MD simula-
tions and will present the results of the compound
selection for testing.
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